FDA approves Watson Pharmaceuticals' twice-yearly Trelstar formulation for prostate cancer March 15, 2010 No Comments
FDA grants approval to Daiichi's hypertension treatment Benicar in pediatric patients Feb. 12, 2010 No Comments
FDA grants marketing approval to Acorda's Ampyra to improve walking in MS patients Jan. 25, 2010 No Comments
RSS